{"id":340194,"date":"2026-11-05T12:01:35","date_gmt":"2026-11-05T06:31:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=340194"},"modified":"2026-11-05T12:01:35","modified_gmt":"2026-11-05T06:31:35","slug":"high-revenue-growth-stocks-to-buy","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/","title":{"rendered":"High Revenue Growth Stocks to Buy in November 2026: 5 Names on the Watchlist"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Narayana Rs 1,932. Paradeep Rs 137.21. RR Kabel Rs 2,018. Endurance Rs 2,507. Metropolis Healthcare Rs 581.25. NSE closing prices, 4 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Five high revenue growth stocks to buy on the November 2026 watchlist are Narayana Hrudayalaya, Paradeep Phosphates, RR Kabel, Endurance Technologies and Metropolis Healthcare. All five grew revenue in their latest full year, and all five also grew net profit. Paradeep Phosphates has the lowest P\/E at 13.38, while RR Kabel leads on return on equity at 19.12%. Check each valuation against your own risk appetite before acting.<\/p>\n<\/p><\/div>\n<p>The high revenue growth stocks to buy in November 2026 start with five listed names: Narayana Hrudayalaya, Paradeep Phosphates, RR Kabel, Endurance Technologies and Metropolis Healthcare. High revenue growth stocks are companies whose sales grew at a fast pace in FY26, which points to rising demand for what they sell.<\/p>\n<p>This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these high revenue growth stocks to buy to a portfolio. All prices are NSE closing prices of 4 November 2026, and financials come from company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=high-revenue-growth-stocks-to-buy\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Which_Are_the_Best_High_Revenue_Growth_Stocks_to_Buy_in_November_2026\" title=\"Which Are the Best High Revenue Growth Stocks to Buy in November 2026?\">Which Are the Best High Revenue Growth Stocks to Buy in November 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Why_These_High_Revenue_Growth_Stocks_to_Buy_Are_in_Focus\" title=\"Why These High Revenue Growth Stocks to Buy Are in Focus\">Why These High Revenue Growth Stocks to Buy Are in Focus<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Narayana_Hrudayalaya_The_Affordable_Care_Specialist_Among_High_Revenue_Growth_Stocks_to_Buy\" title=\"Narayana Hrudayalaya: The Affordable Care Specialist Among High Revenue Growth Stocks to Buy\">Narayana Hrudayalaya: The Affordable Care Specialist Among High Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Paradeep_Phosphates_The_Phosphate_Fertiliser_Producer_Among_High_Revenue_Growth_Stocks_to_Buy\" title=\"Paradeep Phosphates: The Phosphate Fertiliser Producer Among High Revenue Growth Stocks to Buy\">Paradeep Phosphates: The Phosphate Fertiliser Producer Among High Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#RR_Kabel_A_Cables_Name_With_Consumer_Reach_Among_High_Revenue_Growth_Stocks_to_Buy\" title=\"RR Kabel: A Cables Name With Consumer Reach Among High Revenue Growth Stocks to Buy\">RR Kabel: A Cables Name With Consumer Reach Among High Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Endurance_Technologies_The_Two-Wheeler_Parts_Specialist_Among_High_Revenue_Growth_Stocks_to_Buy\" title=\"Endurance Technologies: The Two-Wheeler Parts Specialist Among High Revenue Growth Stocks to Buy\">Endurance Technologies: The Two-Wheeler Parts Specialist Among High Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Metropolis_Healthcare_The_Diagnostics_Network_Among_High_Revenue_Growth_Stocks_to_Buy\" title=\"Metropolis Healthcare: The Diagnostics Network Among High Revenue Growth Stocks to Buy\">Metropolis Healthcare: The Diagnostics Network Among High Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Growth_Snapshot_Latest_Full_Year_and_Latest_Quarter\" title=\"Growth Snapshot: Latest Full Year and Latest Quarter\">Growth Snapshot: Latest Full Year and Latest Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Factors_That_Move_High_Revenue_Growth_Stocks_to_Buy\" title=\"Factors That Move High Revenue Growth Stocks to Buy\">Factors That Move High Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Risks_to_Keep_in_Mind_Before_Buying_High_Revenue_Growth_Stocks\" title=\"Risks to Keep in Mind Before Buying High Revenue Growth Stocks\">Risks to Keep in Mind Before Buying High Revenue Growth Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#How_to_Choose_High_Revenue_Growth_Stocks_to_Buy\" title=\"How to Choose High Revenue Growth Stocks to Buy\">How to Choose High Revenue Growth Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#How_to_Invest_in_High_Revenue_Growth_Stocks\" title=\"How to Invest in High Revenue Growth Stocks\">How to Invest in High Revenue Growth Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Frequently_Asked_Questions_on_High_Revenue_Growth_Stocks_to_Buy\" title=\"Frequently Asked Questions on High Revenue Growth Stocks to Buy\">Frequently Asked Questions on High Revenue Growth Stocks to Buy<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Which_are_the_best_high_revenue_growth_stocks_to_buy_in_November_2026\" title=\"Which are the best high revenue growth stocks to buy in November 2026?\">Which are the best high revenue growth stocks to buy in November 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Is_Narayana_Hrudayalaya_a_good_stock_to_buy_from_this_High_Revenue_Growth_list\" title=\"Is Narayana Hrudayalaya a good stock to buy from this High Revenue Growth list?\">Is Narayana Hrudayalaya a good stock to buy from this High Revenue Growth list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Are_these_high_revenue_growth_stocks_expensive_right_now\" title=\"Are these high revenue growth stocks expensive right now?\">Are these high revenue growth stocks expensive right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Which_of_these_high_revenue_growth_stocks_pay_a_dividend\" title=\"Which of these high revenue growth stocks pay a dividend?\">Which of these high revenue growth stocks pay a dividend?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#Which_stock_on_this_list_has_the_highest_return_on_equity\" title=\"Which stock on this list has the highest return on equity?\">Which stock on this list has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#What_are_the_risks_of_investing_in_high_revenue_growth_stocks\" title=\"What are the risks of investing in high revenue growth stocks?\">What are the risks of investing in high revenue growth stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/high-revenue-growth-stocks-to-buy\/#How_can_I_invest_in_high_revenue_growth_stocks_in_India\" title=\"How can I invest in high revenue growth stocks in India?\">How can I invest in high revenue growth stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Which_Are_the_Best_High_Revenue_Growth_Stocks_to_Buy_in_November_2026\"><\/span><strong>Which Are the Best High Revenue Growth Stocks to Buy in November 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The best high revenue growth stocks to buy in November 2026 for a watchlist are Narayana Hrudayalaya, Paradeep Phosphates, RR Kabel, Endurance Technologies and Metropolis Healthcare. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.<\/p>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"6\">\n<thead>\n<tr>\n<th>Company<\/th>\n<th>CMP (Rs)<\/th>\n<th>Market Cap<\/th>\n<th>P\/E<\/th>\n<th>ROE<\/th>\n<th>Dividend Yield<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/nh\/narayana-hrudayalaya-ltd-share-price-today\">Narayana Hrudayalaya<\/a><\/td>\n<td>1,932<\/td>\n<td>Rs 35,033 crore<\/td>\n<td>42.90<\/td>\n<td>17.76%<\/td>\n<td>0.26%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/paradeep\/paradeep-phosphates-ltd-share-price-today\">Paradeep Phosphates<\/a><\/td>\n<td>137.21<\/td>\n<td>Rs 14,337 crore<\/td>\n<td>13.38<\/td>\n<td>14.69%<\/td>\n<td>1.09%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/rrkabel\/rr-kabel-ltd-share-price-today\">RR Kabel<\/a><\/td>\n<td>2,018<\/td>\n<td>Rs 24,951 crore<\/td>\n<td>41.06<\/td>\n<td>19.12%<\/td>\n<td>0.43%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/endurance\/endurance-technologies-ltd-share-price-today\">Endurance Technologies<\/a><\/td>\n<td>2,507<\/td>\n<td>Rs 32,395 crore<\/td>\n<td>33.40<\/td>\n<td>13.91%<\/td>\n<td>0.50%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/metropolis\/metropolis-healthcare-ltd-share-price-today\">Metropolis Healthcare<\/a><\/td>\n<td>581.25<\/td>\n<td>Rs 11,493 crore<\/td>\n<td>56.65<\/td>\n<td>12.56%<\/td>\n<td>0.90%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>On valuation, Narayana Hrudayalaya and Paradeep Phosphates trade below the industry P\/E; RR Kabel, Endurance Technologies and Metropolis Healthcare sit close to it. Valuation is the first filter for any high revenue growth stocks to buy list, and it is covered again in the risk section.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_These_High_Revenue_Growth_Stocks_to_Buy_Are_in_Focus\"><\/span><strong>Why These High Revenue Growth Stocks to Buy Are in Focus<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In this list, FY26 revenue grew between roughly 24% and 43% year on year, and FY26 net profit grew for every company. The list covers a hospital chain, a fertiliser maker, a wires and cables maker, an auto components maker and a diagnostics company. Investors comparing the best high revenue growth stocks in India usually check whether sales growth is reaching profit and whether it can last.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Narayana_Hrudayalaya_The_Affordable_Care_Specialist_Among_High_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Narayana Hrudayalaya: The Affordable Care Specialist Among High Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Narayana Hrudayalaya is a hospital chain known for affordable cardiac and multi-speciality care. At Rs 1,932, the stock has a market capitalisation of Rs 35,033 crore and trades at 42.90 times earnings, while the industry P\/E is 61.50.<\/p>\n<p>Reported numbers show FY26 revenue of Rs 7,996 crore, up 43.4% year on year, with net profit at Rs 810 crore, up 2.6%. The June 2026 quarter added revenue of Rs 2,719 crore (up 77.6%) and net profit of Rs 207 crore (up 5.4%).<\/p>\n<p>Return on equity is 17.76%, debt-to-equity is 1.29, and the dividend yield is 0.26%. Promoters hold 63.27%, foreign institutions 9.01% and domestic institutions 10.68% as of September 2026. Domestic institutional holding has risen from 7.76% to 10.68% over the last year. A point to keep in view: debt is higher than most names on this list.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Paradeep_Phosphates_The_Phosphate_Fertiliser_Producer_Among_High_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Paradeep Phosphates: The Phosphate Fertiliser Producer Among High Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Paradeep Phosphates is a DAP and NPK fertiliser producer based in eastern India. Its market capitalisation is Rs 14,337 crore, the share price is Rs 137.21 and the P\/E of 13.38 compares with an industry P\/E of 20.30.<\/p>\n<p>Over FY26, net profit rose 50.5% to Rs 996 crore on revenue of Rs 21,973 crore, which was up 28.4%. The latest quarter, the June 2026 quarter, brought revenue of Rs 6,146 crore, up 35.4% year on year, and net profit of Rs 393 crore, up 23.9%.<\/p>\n<p>Return on equity is 14.69%, debt-to-equity is 1.02, and the dividend yield is 1.09%. Promoters hold 57.85%, foreign institutions 4.79% and domestic institutions 20.26% as of September 2026. Domestic institutional holding has risen from 12.99% to 20.26% over the last year. A point to keep in view: debt is higher than most names on this list.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check High Revenue Growth Stocks Live on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"RR_Kabel_A_Cables_Name_With_Consumer_Reach_Among_High_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>RR Kabel: A Cables Name With Consumer Reach Among High Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>RR Kabel is a wires and cables maker that also sells fans, lighting and other consumer electricals. The stock trades at Rs 2,018 with a market capitalisation of Rs 24,951 crore and a P\/E of 41.06, against an industry P\/E of 39.42.<\/p>\n<p>FY26 revenue rose 27.5% to Rs 9,779 crore and net profit rose 58.0% to Rs 492 crore. In the September 2026 quarter, revenue grew 51.5% year on year to Rs 3,303 crore, while net profit grew 55.3% to Rs 181 crore.<\/p>\n<p>Return on equity is 19.12%, debt-to-equity is 0.13, and the dividend yield is 0.43%. Promoters hold 59.32%, foreign institutions 12.51% and domestic institutions 10.25% as of September 2026. Foreign institutional holding has risen from 8.18% to 12.51% over the last year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Endurance_Technologies_The_Two-Wheeler_Parts_Specialist_Among_High_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Endurance Technologies: The Two-Wheeler Parts Specialist Among High Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Endurance Technologies is a maker of suspension, braking and casting parts for two-wheelers and cars, with a European subsidiary. At Rs 2,507, the stock has a market capitalisation of Rs 32,395 crore and trades at 33.40 times earnings, while the industry P\/E is 36.13.<\/p>\n<p>Reported numbers show FY26 revenue of Rs 14,720 crore, up 26.1% year on year, with net profit at Rs 952 crore, up 13.8%. The June 2026 quarter added revenue of Rs 4,348 crore (up 29.6%) and net profit of Rs 245 crore (up 8.0%).<\/p>\n<p>Return on equity is 13.91%, debt-to-equity is 0.19, and the dividend yield is 0.50%. Promoters hold 75.00%, foreign institutions 12.07% and domestic institutions 10.48% as of September 2026. Domestic institutional holding has risen from 9.06% to 10.48% over the last year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Metropolis_Healthcare_The_Diagnostics_Network_Among_High_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Metropolis Healthcare: The Diagnostics Network Among High Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Metropolis Healthcare is a diagnostics company with labs and collection centres across India and overseas. Its market capitalisation is Rs 11,493 crore, the share price is Rs 581.25 and the P\/E of 56.65 compares with an industry P\/E of 61.50.<\/p>\n<p>Over FY26, net profit rose 31.4% to Rs 191 crore on revenue of Rs 1,671 crore, which was up 24.1%. The latest quarter, the June 2026 quarter, brought revenue of Rs 455 crore, up 15.7% year on year, and net profit of Rs 56.9 crore, up 25.7%.<\/p>\n<p>Return on equity is 12.56%, debt-to-equity is 0.15, and the dividend yield is 0.90%. Promoters hold 47.82%, foreign institutions 11.67% and domestic institutions 35.49% as of September 2026. Domestic institutional holding has risen from 33.10% to 35.49% over the last year.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track these high revenue growth stocks live and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Growth_Snapshot_Latest_Full_Year_and_Latest_Quarter\"><\/span><strong>Growth Snapshot: Latest Full Year and Latest Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares year-on-year growth in revenue and net profit for all five high revenue growth stocks, using filed results.<\/p>\n<table style=\"border-collapse:collapse;width:100%;\" border=\"1\" cellpadding=\"6\">\n<thead>\n<tr>\n<th>Company<\/th>\n<th>Full-Year Revenue Growth<\/th>\n<th>Full-Year Profit Growth<\/th>\n<th>Latest Quarter<\/th>\n<th>Quarter Revenue Growth<\/th>\n<th>Quarter Profit Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Narayana Hrudayalaya<\/td>\n<td>43.4%<\/td>\n<td>2.6%<\/td>\n<td>Jun 2026<\/td>\n<td>77.6%<\/td>\n<td>5.4%<\/td>\n<\/tr>\n<tr>\n<td>Paradeep Phosphates<\/td>\n<td>28.4%<\/td>\n<td>50.5%<\/td>\n<td>Jun 2026<\/td>\n<td>35.4%<\/td>\n<td>23.9%<\/td>\n<\/tr>\n<tr>\n<td>RR Kabel<\/td>\n<td>27.5%<\/td>\n<td>58.0%<\/td>\n<td>Sep 2026<\/td>\n<td>51.5%<\/td>\n<td>55.3%<\/td>\n<\/tr>\n<tr>\n<td>Endurance Technologies<\/td>\n<td>26.1%<\/td>\n<td>13.8%<\/td>\n<td>Jun 2026<\/td>\n<td>29.6%<\/td>\n<td>8.0%<\/td>\n<\/tr>\n<tr>\n<td>Metropolis Healthcare<\/td>\n<td>24.1%<\/td>\n<td>31.4%<\/td>\n<td>Jun 2026<\/td>\n<td>15.7%<\/td>\n<td>25.7%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Factors_That_Move_High_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Factors That Move High Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four factors tend to drive high revenue growth stocks, and each one is worth checking before a purchase.<\/p>\n<ul>\n<li><strong>Sales trend:<\/strong> Check growth across several quarters.<\/li>\n<li><strong>Profit conversion:<\/strong> Sales growth should lift profit.<\/li>\n<li><strong>Capacity:<\/strong> Fast growth needs beds, plants or labs to keep pace.<\/li>\n<li><strong>Valuation:<\/strong> Growth is often already priced in.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Keep_in_Mind_Before_Buying_High_Revenue_Growth_Stocks\"><\/span><strong>Risks to Keep in Mind Before Buying High Revenue Growth Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The first risk is that fast growth can slow once the sales base gets larger. The second is that expansion may bring higher spending or borrowings, which can weigh on margins. Hospitals, fertilisers, cables and auto parts also follow different cycles.<\/p>\n<p>On the numbers, Metropolis Healthcare trades at the highest P\/E on this list at 56.65, so its earnings need to keep growing to support the price. High Revenue Growth stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_High_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>How to Choose High Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Compare with profit:<\/strong> Revenue should lead to earnings.<\/li>\n<li><strong>Watch margins:<\/strong> Rising sales with thinner margins need a closer look.<\/li>\n<li><strong>Review debt:<\/strong> Expansion can add borrowings.<\/li>\n<li><strong>Study valuation:<\/strong> Compare P\/E with the industry.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_High_Revenue_Growth_Stocks\"><\/span><strong>How to Invest in High Revenue Growth Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Shortlist two or three companies from this list that match your risk appetite.<\/li>\n<li>Open the Univest Screener and compare P\/E, ROE and debt for each stock.<\/li>\n<li>Check the latest quarterly results and shareholding pattern on NSE or BSE.<\/li>\n<li>Decide an amount you can hold for three to five years and split it into two or three purchases.<\/li>\n<li>Review the holding after every quarterly result instead of reacting to daily price moves.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Paradeep Phosphates offers the lowest P\/E on this list at 13.38, RR Kabel has the highest return on equity at 19.12%, and RR Kabel posted the fastest net profit growth in its latest full year at 58.0%. Among the best high revenue growth stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these high revenue growth stocks to buy.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_High_Revenue_Growth_Stocks_to_Buy\"><\/span><strong>Frequently Asked Questions on High Revenue Growth Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_high_revenue_growth_stocks_to_buy_in_November_2026\"><\/span><strong>Which are the best high revenue growth stocks to buy in November 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The five high revenue growth stocks on the November 2026 watchlist are Narayana Hrudayalaya, Paradeep Phosphates, RR Kabel, Endurance Technologies and Metropolis Healthcare. Paradeep Phosphates has the lowest P\/E at 13.38, RR Kabel has the highest ROE at 19.12%, and RR Kabel grew net profit 58.0% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Narayana_Hrudayalaya_a_good_stock_to_buy_from_this_High_Revenue_Growth_list\"><\/span><strong>Is Narayana Hrudayalaya a good stock to buy from this High Revenue Growth list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Narayana Hrudayalaya is the largest company on this list with a market capitalisation of Rs 35,033 crore and a P\/E of 42.90 against an industry P\/E of 61.50. Its FY26 revenue rose 43.4% and net profit rose 2.6%, with return on equity at 17.76%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_these_high_revenue_growth_stocks_expensive_right_now\"><\/span><strong>Are these high revenue growth stocks expensive right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Valuations vary across the group. Narayana Hrudayalaya trades at a P\/E of 42.90, Paradeep Phosphates trades at a P\/E of 13.38, RR Kabel trades at a P\/E of 41.06, Endurance Technologies trades at a P\/E of 33.40, Metropolis Healthcare trades at a P\/E of 56.65, against industry multiples ranging from 20.30 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_high_revenue_growth_stocks_pay_a_dividend\"><\/span><strong>Which of these high revenue growth stocks pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dividend yields on this list are Narayana Hrudayalaya 0.26%, Paradeep Phosphates 1.09%, RR Kabel 0.43%, Endurance Technologies 0.50%, Metropolis Healthcare 0.90%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_stock_on_this_list_has_the_highest_return_on_equity\"><\/span><strong>Which stock on this list has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> RR Kabel has the highest ROE on this list at 19.12%, followed by Narayana Hrudayalaya at 17.76% and Paradeep Phosphates at 14.69%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_high_revenue_growth_stocks\"><\/span><strong>What are the risks of investing in high revenue growth stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are a slowdown as the sales base grows, higher spending or debt behind expansion and sector cycles. On this list, Metropolis Healthcare trades at the highest P\/E of 56.65, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_high_revenue_growth_stocks_in_India\"><\/span><strong>How can I invest in high revenue growth stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P\/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best high revenue growth stocks to buy in November 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The five high revenue growth stocks on the November 2026 watchlist are Narayana Hrudayalaya, Paradeep Phosphates, RR Kabel, Endurance Technologies and Metropolis Healthcare. Paradeep Phosphates has the lowest P\/E at 13.38, RR Kabel has the highest ROE at 19.12%, and RR Kabel grew net profit 58.0% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.\"}},{\"@type\":\"Question\",\"name\":\"Is Narayana Hrudayalaya a good stock to buy from this High Revenue Growth list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Narayana Hrudayalaya is the largest company on this list with a market capitalisation of Rs 35,033 crore and a P\/E of 42.90 against an industry P\/E of 61.50. Its FY26 revenue rose 43.4% and net profit rose 2.6%, with return on equity at 17.76%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.\"}},{\"@type\":\"Question\",\"name\":\"Are these high revenue growth stocks expensive right now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Valuations vary across the group. Narayana Hrudayalaya trades at a P\/E of 42.90, Paradeep Phosphates trades at a P\/E of 13.38, RR Kabel trades at a P\/E of 41.06, Endurance Technologies trades at a P\/E of 33.40, Metropolis Healthcare trades at a P\/E of 56.65, against industry multiples ranging from 20.30 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.\"}},{\"@type\":\"Question\",\"name\":\"Which of these high revenue growth stocks pay a dividend?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dividend yields on this list are Narayana Hrudayalaya 0.26%, Paradeep Phosphates 1.09%, RR Kabel 0.43%, Endurance Technologies 0.50%, Metropolis Healthcare 0.90%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.\"}},{\"@type\":\"Question\",\"name\":\"Which stock on this list has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"RR Kabel has the highest ROE on this list at 19.12%, followed by Narayana Hrudayalaya at 17.76% and Paradeep Phosphates at 14.69%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in high revenue growth stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are a slowdown as the sales base grows, higher spending or debt behind expansion and sector cycles. On this list, Metropolis Healthcare trades at the highest P\/E of 56.65, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in high revenue growth stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P\/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Five high revenue growth stocks on the November 2026 watchlist with FY26 growth, valuation, ROE, shareholding and risks for Narayana, Paradeep, RR Kabel, Endurance and Metropolis Healthcare.<\/p>\n","protected":false},"author":28,"featured_media":340193,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[7001,13089,7040,7035,20368],"class_list":["post-340194","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-endurance-technologies","tag-high-revenue-growth-stocks","tag-narayana-hrudayalaya","tag-rr-kabel","tag-sales-growth-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["340193"],"rank_math_title":["High Revenue Growth Stocks to Buy in Nov 2026: Top 5 Picks"],"rank_math_description":["High Revenue Growth stocks to buy in November 2026: Narayana, Paradeep and RR Kabel, with FY26 growth, valuation, ROE and key risks for each. Data as of 4 Nov 2026."],"rank_math_focus_keyword":["high revenue growth stocks to buy"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/high-revenue-growth-stocks-to-buy-in-november-2026-5-names-on-the-watchlist.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/340194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=340194"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/340194\/revisions"}],"predecessor-version":[{"id":340195,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/340194\/revisions\/340195"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/340193"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=340194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=340194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=340194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}